Scottish Drug Tariff Part1 AnnexA Zero Discount List

The Scottish Drug Tariff (SDT) is the official schedule that sets reimbursement rates for medicines dispensed by community pharmacies in Scotland. Part1 of the Tariff deals with Prescription Drugs and contains a series of annexes that define pricing rules for different categories of medicines. AnnexA the Zero Discount List is a key component of this framework. It specifies a small group of medicines for which a zero discount rule applies, meaning that no discount can be taken from the standard unit price when calculating the reimbursement amount.

Why a Zero Discount List Exists

Most medicines listed on the SDT are subject to a statutory discount (currently 7%). The discount reduces the amount payable by the NHS to the pharmacy and is intended to reflect the difference between the list price and the procurement cost that pharmacists achieve through bulk purchasing. However, for certain medicines the discount would be inappropriate for one or more of the following reasons:

• Clinical necessity The drug may be a lifesaving or highrisk medication where any discount would compromise supply.
• Contractual pricing Some manufacturers have negotiated supply agreements that already include a reduced price, making an additional statutory discount redundant.
• Regulatory constraints Certain products, such as controlled substances or specialuse items, have statutory provisions that forbid the use of discounts.
• Market dynamics Lowvolume or orphan drugs may not have a competitive market, meaning that a discount would not be achievable.

How the Zero Discount Rule Works

When a pharmacist dispenses a medicine that appears on AnnexA, the reimbursement is calculated using the full list price (the tariff unit price) without applying the 7% discount. The formula can be expressed as:

Reimbursement = QuantityUnit Price (no discount applied)

If the same medicine is also listed under a different category that allows a discount, the pharmacy must follow the specific guidance in the Tariff to determine which rule overrides. Usually, the AnnexA rule takes precedence because it is a statutory exception.

Key Medicines on the Zero Discount List (as of the latest amendment)

The list is deliberately small and is updated only when a compelling reason exists. Below is a representative selection of the medicines currently covered by the zerodiscount provision.

Impact on Pharmacists and NHSScotland

Understanding whether a product falls under AnnexA is crucial for accurate claims submission. The main impacts are:

• Financial planning Pharmacies must anticipate that zerodiscount items will yield higher reimbursements, affecting cashflow forecasts.
• Stock management Because many zerodiscount medicines are highcost, pharmacists often keep tighter inventory controls.
• Administrative burden Claims for zerodiscount items must be flagged correctly in the electronic prescribing system to avoid underpayment.

Regulatory Guidance and Updates

The Scottish Medicines Consortium (SMC) and NHSScotland jointly publish amendments to the Tariff. Any change to AnnexA is announced in the SDT Supplementary Notice and is made effective from the start of the next month. Pharmacists are urged to subscribe to the NHS Scotland Pharmacy Updates mailing list to stay informed.

How to Check Whether a Medicine Is on the Zero Discount List

1. Log in to the NHS Scotland Tariff portal using your pharmacy credentials.
2. Select Part1 Prescription Drugs then AnnexA Zero Discount List.
3. Search by BNF code, brand name, or active ingredient.
4. Confirm the listed unit price and the Zero Discount flag before submitting a claim.

Common Questions (FAQ)

Q1 Can a pharmacy apply a discount voluntarily on a zerodiscount medicine?

No. The statutory rule prohibits taking any discount from the listed price for these items. If a pharmacy offers a voluntary discount to a patient, it must be recorded separately and cannot affect the NHS reimbursement amount.

Q2 What happens if a pharmacy mistakenly applies the 7% discount?

The claim will be rejected during the NHS audit process. The pharmacy must resubmit the claim with the correct calculation, and the NHS may impose a small administrative penalty for the error.

Q3 Are there any exemptions for specific patient groups?

The zerodiscount rule applies to all patients regardless of age, diagnosis, or eligibility for other programmes. The rule is purely a pricing exception.

Q4 How often is AnnexA reviewed?

Review cycles are typically annual, though interim updates may occur if market conditions change dramatically (e.g., a new generic launch or a price renegotiation).

Future Directions

There is ongoing discussion within NHSScotland about expanding the zerodiscount framework to include certain biologics and genetherapy products. The goal is to ensure that pricing mechanisms keep pace with rapid advances in pharmacotherapy while protecting the sustainability of the public health system.

Stakeholders are encouraged to submit comments on proposed amendments through the NHS Scotland public consultation portal before the quarterly deadline.

Conclusion

The Part1 AnnexA Zero Discount List is a targeted exception within the Scottish Drug Tariff that safeguards the supply and appropriate reimbursement of highvalue or specialised medicines. By clearly identifying which products are exempt from the statutory discount, the list provides certainty for both pharmacies and the NHS. Ongoing monitoring and transparent updates ensure the list remains fit for purpose as the therapeutic landscape evolves.